Somatic NRAS mutation in patient with generalized lymphatic anomaly

Keyphrases

• Generalized Lymphatic Anomaly 100%
• NRAS mutation 100%
• Lymphangiomatosis 100%
• Etiology 50%
• Drug Effects 50%
• Mouse Model System 50%
• Internal Organs 50%
• Mammalian Target of Rapamycin (mTOR) 50%
• Zebrafish Model 50%
• Rare Diseases 50%
• Survival Rate 50%
• Endothelial Cells 50%
• Respiratory Failure 50%
• Tube Formation 50%
• Downstream Effectors 50%
• Proliferation Rate 50%
• Lymphatic System 50%
• Lymphatic Vessels 50%
• Respiratory Death 50%
• Somatic mutation 50%
• Disease Genes 50%
• Whole Exome Sequencing 50%

Medicine and Dentistry

• Lymphatic Anomaly 100%
• Lymphangiomatosis 100%
• Somatics 100%
• Diseases 100%
• Mammalian Target of Rapamycin 50%
• Endothelial Cell 50%
• Rare Disease 50%
• Somatic Mutation 50%
• Respiratory Failure 50%
• Lymph Duct 50%
• Lymphatic System 50%
• Exome Sequencing 50%
• Survival Rate 50%